BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8104619)

  • 1. Regulation of transglutaminase activity by GTP in digitonin permeabilized Yoshida tumor cells.
    Bergamini CM; Signorini M; Caselli L; Melandri P
    Biochem Mol Biol Int; 1993 Jul; 30(4):727-32. PubMed ID: 8104619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II.
    Feng JF; Readon M; Yadav SP; Im MJ
    Biochemistry; 1999 Aug; 38(33):10743-9. PubMed ID: 10451369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GTP is required to stabilize and display transamidation activity of transglutaminase 2.
    Jeon JH; Cho SY; Kim CW; Shin DM; Kweon JC; Choi KH; Park SC; Kim IG
    Biochem Biophys Res Commun; 2002 Jun; 294(4):818-22. PubMed ID: 12061780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme.
    Upchurch HF; Conway E; Patterson MK; Maxwell MD
    J Cell Physiol; 1991 Dec; 149(3):375-82. PubMed ID: 1683874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP.
    Iismaa SE; Chung L; Wu MJ; Teller DC; Yee VC; Graham RM
    Biochemistry; 1997 Sep; 36(39):11655-64. PubMed ID: 9305955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GTP, an inhibitor of transglutaminases, is hydrolyzed by tissue-type transglutaminase (TGase 2) but not by epidermal-type transglutaminase (TGase 3).
    Hitomi K; Ikura K; Maki M
    Biosci Biotechnol Biochem; 2000 Mar; 64(3):657-9. PubMed ID: 10803976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase.
    Monsonego A; Friedmann I; Shani Y; Eisenstein M; Schwartz M
    J Mol Biol; 1998 Oct; 282(4):713-20. PubMed ID: 9743620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium pretreatment induces the decrease in epidermal growth factor binding through the activation of transglutaminase in isolated liver membrane.
    Katoh S; Hashimoto M; Kohno H; Ohkubo Y
    Arch Biochem Biophys; 1993 Jun; 303(2):421-8. PubMed ID: 8099784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
    Case A; Stein RL
    Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage.
    Summey BT; Graff RD; Lai TS; Greenberg CS; Lee GM
    J Orthop Res; 2002 Jan; 20(1):76-82. PubMed ID: 11853093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging structural understanding of transglutaminase 3.
    Ahvazi B; Boeshans KM; Rastinejad F
    J Struct Biol; 2004 Aug; 147(2):200-7. PubMed ID: 15193648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 50 KDa protein modulates guanine nucleotide binding of transglutaminase II.
    Baek KJ; Das T; Gray CD; Desai S; Hwang KC; Gacchui R; Ludwig M; Im MJ
    Biochemistry; 1996 Feb; 35(8):2651-7. PubMed ID: 8611570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells.
    Elsässer HP; MacDonald R; Dienst M; Kern HF
    Eur J Cell Biol; 1993 Aug; 61(2):321-8. PubMed ID: 7901019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 activity promotes membrane resealing after mechanical damage in the lung cancer cell line A549.
    Kawai Y; Wada F; Sugimura Y; Maki M; Hitomi K
    Cell Biol Int; 2008 Aug; 32(8):928-34. PubMed ID: 18474442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase activity in Yoshida ascites tumor cells.
    Vanella A; Geremia E; Pinturo R; Bernardini R
    Life Sci; 1983 Aug; 33(6):555-9. PubMed ID: 6136887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human recombinant transglutaminase 1 purified from baculovirus-infected insect cells.
    Hitomi K; Yamagiwa Y; Ikura K; Yamanishi K; Maki M
    Biosci Biotechnol Biochem; 2000 Oct; 64(10):2128-37. PubMed ID: 11129585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor induces transglutaminase activity that negatively regulates the growth signal in primary cultured hepatocytes.
    Katoh S; Nakagawa N; Yano Y; Satoh K; Kohno H; Ohkubo Y; Suzuki T; Kitani K
    Exp Cell Res; 1996 Feb; 222(2):255-61. PubMed ID: 8598211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct characteristic of Galpha(h) (transglutaminase II) by compartment: GTPase and transglutaminase activities.
    Park H; Park ES; Lee HS; Yun HY; Kwon NS; Baek KJ
    Biochem Biophys Res Commun; 2001 Jun; 284(2):496-500. PubMed ID: 11394908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9.
    Ahn JS; Kim MK; Hahn JH; Park JH; Park KH; Cho BR; Park SB; Kim DJ
    Biochem Biophys Res Commun; 2008 Nov; 376(4):743-7. PubMed ID: 18809380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rat liver transglutaminase by nucleotides.
    Kawashima S
    Experientia; 1991 Jul; 47(7):709-12. PubMed ID: 1676683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.